Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Brigatinib 180mg tablets
0801050CPAAAAAA
|
Brigatinib | Brigatinib | Malignant Disease and Immunosuppression | No data available |
|
Brigatinib 30mg tablets
0801050CPAAABAB
|
Brigatinib | Brigatinib | Malignant Disease and Immunosuppression | No data available |
|
Brigatinib 90mg tablets
0801050CPAAACAC
|
Brigatinib | Brigatinib | Malignant Disease and Immunosuppression | No data available |
|
Brigatinib 90mg tablets and Brigatinib 180mg tablets
0801050CPAAADAD
|
Brigatinib | Brigatinib | Malignant Disease and Immunosuppression | No data available |
|
Brillant SilFlate all silicone catheter female 12Ch-24Ch
21020000956
|
Brillant SilFlate all silicone catheter female 12Ch-24Ch | Catheters | Appliances | No data available |
|
Brillant SilFlate all silicone catheter male 12Ch-24Ch
21020000955
|
Brillant SilFlate all silicone catheter male 12Ch-24Ch | Catheters | Appliances | No data available |
|
Britacef 1.5g powder for solution for injection vials
0501021J0BCACAC
|
Britacef | Cefuroxime sodium | Infections | No data available |
|
Britacef 250mg powder for solution for injection vials
0501021J0BCAAAA
|
Britacef | Cefuroxime sodium | Infections | No data available |
|
Britacef 750mg powder for solution for injection vials
0501021J0BCABAB
|
Britacef | Cefuroxime sodium | Infections | No data available |
|
BritLofex 200microgram tablets
0410030D0BBAAAA
|
BritLofex | Lofexidine hydrochloride | Central Nervous System | No data available |
|
Briviact 50mg/5ml solution for injection vials
0408010ALBBAFAF
|
Briviact | Brivaracetam | Central Nervous System | No data available |
|
Brochlor 0.5% eye drops
1103010C0BHAAAA
|
Brochlor | Chloramphenicol | Eye | No data available |
|
Brochlor 1% eye ointment
1103010C0BHABAD
|
Brochlor | Chloramphenicol | Eye | No data available |
|
Brodalumab 210mg/1.5ml inj pre-filled syringes
1305030E0AAAAAA
|
Brodalumab | Brodalumab | Skin | No data available |
|
Brodilaten 5mg/2.5ml nebuliser solution unit dose ampoules
0301011R0CBADCE
|
Brodilaten | Salbutamol | Respiratory System | No data available |
|
Broflex 5mg/5ml syrup
0409020C0BCAAAC
|
Broflex | Trihexyphenidyl hydrochloride | Central Nervous System | No data available |
|
Brolene 0.15% eye ointment
1103010E0BBAAAA
|
Brolene (Eye ointment) | Dibrompropamidine isetionate | Eye | No data available |
|
Bromazepam 3mg tablets
0401020G0AAAAAA
|
Bromazepam | Bromazepam | Central Nervous System | No data available |
|
Bromocriptine 10mg/5ml oral suspension
0607010B0AAAKAK
|
Bromocriptine mesilate | Bromocriptine | Endocrine System | No data available |
|
Bromocriptine 1mg tablets
0607010B0AAACAC
|
Bromocriptine mesilate | Bromocriptine | Endocrine System | No data available |
|
Bromocriptine 1mg/5ml oral suspension
0607010B0AAAIAI
|
Bromocriptine mesilate | Bromocriptine | Endocrine System | No data available |
|
Bromocriptine 2.5mg/5ml oral suspension
0607010B0AAAGAG
|
Bromocriptine mesilate | Bromocriptine | Endocrine System | No data available |
|
Bromocriptine 200micrograms/5ml oral suspension
0607010B0AAAFAF
|
Bromocriptine mesilate | Bromocriptine | Endocrine System | No data available |
|
Bromocriptine 20mg/5ml oral suspension
0607010B0AAAHAH
|
Bromocriptine mesilate | Bromocriptine | Endocrine System | No data available |
|
Bromocriptine 5mg/5ml oral suspension
0607010B0AAAJAJ
|
Bromocriptine mesilate | Bromocriptine | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.